Brian Adams, Chief Legal Officer at Relay Therapeutics, Inc. (RLAY), sold 298 shares at $2.84 ($846) on 2025-03-27, disclosed to the SEC on 2025-03-31.
Seasonal sale ($846) by Chief Legal Officer — this insider has traded RLAY in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| RLAY | SELL | 2025-04-30 | $44K | — | Filing → |
| RLAY | SELL | 2025-01-30 | $496K | — | Filing → |
| RLAY | SELL | 2024-12-31 | $1K | — | Filing → |